| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |